Description:

ALNY refers to Alnylam Pharmaceuticals, Inc., a biopharmaceutical company listed on the New York Stock Exchange (NYSE). Alnylam is dedicated to developing innovative RNA interference (RNAi) therapeutics for a wide range of diseases. The company's pioneering work in this field has positioned it as a leader in the application of RNAi technology to treat genetic conditions and other serious illnesses. Through its robust pipeline and strategic partnerships, Alnylam continues to advance treatments that aim to improve patient outcomes significantly.

Data:

Yields: